About teneliglipt in
Dipeptidyl peptidase-4 (DPP-4) inhibitor
Used for
- Type 2 diabetes, alongside diet and exercise
Usual adult dose
Usually 20 mg once daily; may increase to 40 mg once daily if needed.
Common side effects
- Low blood sugar, especially with insulin or sulfonylureas
- Headache
- Constipation or nausea
- Rash or itching
Important warnings
- Not for type 1 diabetes or diabetic ketoacidosis
- Rarely, pancreatitis or severe allergic reactions can occur
- Use caution with heart failure or kidney problems
- Low blood sugar risk increases with insulin or sulfonylureas
Pregnancy
Not recommended; safety information in pregnancy is limited.
Breastfeeding
Avoid unless prescribed; effects on breastfed infants are not well established.
Interactions
- Insulin or sulfonylureas increase low blood sugar risk
- Strong CYP3A4 inhibitors may increase teneligliptin levels
- Rifampicin may reduce teneligliptin levels
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.